Dedicated to Endocrinological Discoveries
Therapeutic Areas > Diabetic Care >
Opglucon™ MR
- Award-winning, innovative Modified-Release technology.
- Optimal 24-hour glycemic control.
- Excellent patient compliance with once-daily dosing.
- Protects β-Cells against hyperglycemia
- Induces oxidative stress.
Opglucon™ MR is recommended for adults with type II diabetes, in association with dietary measures and with physical exercise, when these measures alone are not sufficient to obtain normal blood glucose levels.
Click here for more of Opglucon™ MR’s prescribing information
